Itami, Japan

Fumio Nishikaku


Average Co-Inventor Count = 5.9

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1990-2000

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Fumio Nishikaku: Innovator in Pharmaceutical Chemistry

Introduction

Fumio Nishikaku is a notable inventor based in Itami, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of therapeutic drugs. With a total of four patents to his name, Nishikaku's work focuses on innovative compounds that address critical health issues.

Latest Patents

Nishikaku's latest patents include advancements in isoxazole derivatives. These compounds are represented by a specific formula and are recognized for their potential as therapeutic drugs for autoimmune and inflammatory diseases. Another significant patent involves aminoazole derivatives, which outlines a compound formula and its production and use in medical applications.

Career Highlights

Throughout his career, Fumio Nishikaku has been associated with Sumitomo Pharmaceuticals Company Limited. His work has been instrumental in advancing the company's research and development efforts in the pharmaceutical sector. Nishikaku's innovative approach has led to the creation of valuable compounds that have the potential to improve patient outcomes.

Collaborations

Nishikaku has collaborated with esteemed colleagues, including Yukinori Ozato and Nobuhiko Tamura. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking discoveries in pharmaceutical chemistry.

Conclusion

Fumio Nishikaku's contributions to the field of pharmaceutical chemistry are noteworthy. His innovative patents and collaborations reflect his commitment to advancing medical science. Through his work, he continues to make a significant impact on the development of therapeutic drugs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…